Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


The effects of diet on prostate cancer outcomes

The highest risk of death from prostate cancer is associated with increased waist circumference, increased blood pressure, hypertension, type 2 diabetes and obesity; thus, therapies that can reduce blood glucose levels have the potential to improve patient outcomes. The therapeutic benefits of low-carbohydrate and fasting-mimicking diets in patients with prostate cancer have been investigated in two recent studies.

Your institute does not have access to this article

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. Lavalette, C. et al. Abdominal obesity and prostate cancer risk: epidemiological evidence from the EPICAP study. Oncotarget 9, 34485–34494 (2018).

    Article  Google Scholar 

  2. Häggström, C. et al. Prospective study on metabolic factors and risk of prostate cancer. Cancer 118, 6199–6206 (2012).

    Article  Google Scholar 

  3. Geng, J.-H. et al. Metabolic syndrome and its pharmacologic treatment are associated with the time to castration-resistant prostate cancer. Prostate Cancer Prostatic Dis. (2022).

    Article  PubMed  Google Scholar 

  4. Mohamedali, H. Z., Breunis, H., Timilshina, N. & Alibhai, S. M. H. Changes in blood glucose and cholesterol levels due to androgen deprivation therapy in men with non-metastatic prostate cancer. Can. Urol. Assoc. J. 5, 28–32 (2011).

    Article  Google Scholar 

  5. Chi, J.-T. et al. Serum metabolomic analysis of men on a low-carbohydrate diet for biochemically recurrent prostate cancer reveals the potential role of ketogenesis to slow tumor growth: a secondary analysis of the CAPS2 diet trial. Prostate Cancer Prostatic Dis. (2022).

    Article  PubMed  Google Scholar 

  6. Seyfried, T. N., Arismendi-Morillo, G., Mukherjee, P. & Chinopoulos, C. On the origin of ATP synthesis in cancer. iScience 23, 101761 (2020).

    CAS  Article  Google Scholar 

  7. Seyfried, T. N., Yu, G., Maroon, J. C. & D’Agostino, D. P. Press-pulse: a novel therapeutic strategy for the metabolic management of cancer. Nutr. Metab. 14, 19 (2017).

    Article  Google Scholar 

  8. Fay-Watt, V. et al. The impact of a fasting mimicking diet on the metabolic health of a prospective cohort of patients with prostate cancer: a pilot implementation study. Prostate Cancer Prostatic Dis. (2022).

    Article  PubMed  Google Scholar 

  9. Vayalil, P. K. & Landar, A. Mitochondrial oncobioenergetic index: a potential biomarker to predict progression from indolent to aggressive prostate cancer. Oncotarget 6, 43065–43080 (2015).

    Article  Google Scholar 

  10. Lopaschuk, G. D., Hess, D. A. & Verma, S. Ketones regulate endothelial homeostasis. Cell Metab. 34, 513–515 (2022).

    CAS  Article  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Thomas N. Seyfried.

Ethics declarations

Competing interests

The author declares no competing interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Seyfried, T.N. The effects of diet on prostate cancer outcomes. Nat Rev Urol 19, 389–390 (2022).

Download citation

  • Published:

  • Issue Date:

  • DOI:


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing